XTL Biopharma (XTLB) Reports Q2 Loss of $0.002/Share
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
XTL Biopharma (NASDAQ: XTLB) reported Q2 EPS of $-0.002, versus $-0.001 reported last year.
For earnings history and earnings-related data on XTL Biopharma (XTLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Caterpillar (CAT) Tops Q3 EPS by 8c, Sales Miss
- Freeport-McMoran (FCX) Misses Q3 EPS by 3c
- First Bancorp. (FBP) Tops Q3 EPS by 1c